Institutional investors hold a majority ownership of ABBV through the 68.98% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.3 Million shares of AbbVie
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.1 Million shares of AbbVie
SCHRODER INVESTMENT MANAGEMENT L... Bought 1.9 Million shares of AbbVie